Physician profile
Bridgette Guthrie
NPI 1437102290
$1,700.76
in general payments reported to CMS, 2019-2025
18 companies · $271 in 2025
The $271 reported for 2025 was more than what 84% of Pediatric Emergency Medicine (Emergency Medicine) providers received nationally (typical 2025 total: $57.68).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $89.65 · 2021: $294 · 2022: $302 · 2023: $215 · 2024: $383 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $430.91 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $244.19 | 2020-2024 | Jornay Pm |
| Tris Pharma INC | $211.65 | 2021-2024 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $182.70 | 2021-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $110.55 | 2019-2025 | Doc Band |
| Shire North American Group INC | $87.52 | 2019 | |
| Pfizer INC. | $82.26 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.46 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $52.65 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $51.00 | 2019-2023 | Cotempla Xr-Odt |
| Kaleo, INC. | $43.66 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $27.00 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $24.44 | 2022 | |
| Seqirus USA INC | $20.77 | 2025 | Flucelvax |
| Vertical Pharmaceuticals, LLC | $19.35 | 2025 | Relexxii |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $15.41 | 2020 | |
| Sanofi Pasteur INC. | $14.16 | 2023 | |
| Merck Sharp & Dohme LLC | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Guthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.